CordenPharma Peptides Platform

CordenPharma Peptides Platform
Product Description

Your Expert Partner for Peptide APIs

  • >> Proven track record delivering world class manufacturing services from early stage to commercial supply, including complex products (e.g., Linaclotide, Enfuvirtide, Mifamurtide, Eptifibatide, Glatiramer, GLP analogues).
  • >> Proprietary process technologies for cost-effective manufacturing and a robust CMC dossier by reduced chemical steps, increased purity, decreased raw material costs, and green approaches to reduce our carbon footprint.
  • >> A unique expertise in Peptides offering access to a wide range of products to meet customer needs.
  • >> Fully-integrated supply from peptide APIs to injectable Drug Products, with backward integration for key starting materials to secure supply chain.
  • >> Multiple manufacturing locations across Europe & the USA offering flexibility of supply while supporting our Business Contingency Plan (BCP).

Corden Pharma International GmbH

  • DE
  • 2015
    On CPHI since
  • 1
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO
Specifications
  • Selling Points
    Experienced Technicians; International Approvals/Standards; Packaging; Place of Origin; Prompt Delivery; Quality Service; Reputation; Small Orders Accepted
  • Supplied from
    Belgium; United States
  • Measured In
    Kg

Corden Pharma International GmbH

  • DE
  • 2015
    On CPHI since
  • 1
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO

More Products from Corden Pharma International GmbH (4)

  • CordenPharma Lipids & Carbohydrate Platform

    Product CordenPharma Lipids & Carbohydrate Platform

    Your Expert Partner for Standard & Proprietary Lipids & Carbohydrates
    • >> A specialized Lipids offering including custom and standard lipids (Glycero-Phospholipids, Sphingolipids, Phosphocholine, Pegylated, and Cationic Lipids). • >> Lipids for support of mRNA vaccine ...
  • CordenPharma Injectables Platform

    Product CordenPharma Injectables Platform

    Your Expert Partner for Clinical & Commercial Injectable Drug Product Supply
    • >> Wide & balanced range of injectable services incl. capability for combining injectable drugs and devices (combination products) • >> Aseptic and Terminal Sterilization Fill & Finish Technologies f...
  • CordenPharma Highly Potent & Oncology Platform

    Product CordenPharma Highly Potent & Oncology Platform

    One Source for Highly Potent & Oncological Products
    • Integrated Supply: APIs & Oral / Sterile Drug Products • State-of-the-art facilities able to handle API and Drug Product of the highest potency • Development, clinical trial and commercial manufacturing • Full-service offering includi...
  • CordenPharma Small Molecules Platform

    Product CordenPharma Small Molecules Platform

    Full-Service Partner of Choice from Advanced Intermediates to Drug Products • Integrated network of cGMP facilities across Europe and US • 1,200 m3 of volumetric capacity in 20 L - 28,000 L reactors with various materials of construction • Clinical (Phase I-III) and ongoing commercial supply to multiple ...

Corden Pharma International GmbH resources (4)

  • News CPHI Frankfurt 2022: Innovator Interview – CordenPharma

    In this interview from CPHI Frankfurt 2022, we speak to Dr Michael Quirmbach of CordenPharma about his role as President and CEO and what CordenPharma is bringing to the pharma industry.
  • Brochure Brochure > Drug Product Services

    Highlights CordenPharma's capabilities for Oral Solid Dosage and Non-Sterile Dosage forms as well as Sterile Injectable Drug Product manufacturing.
  • Video Video > CordenPharma Injectable Drug Product Manufacturing

    Let us accompany you on your Sterile Injectable Drug Product journey under CordenPharma's Injectable Technology Platform. Our CordenPharma Caponango (IT) manufacturing facility produces liquid dosage forms with expertise in GMP Manufacturing, Aspetic Fill & Finish, Terminal Sterilization, Clinical Trials, and Pharma-Logistics.
  • Webinar LIVE WEBINAR > Your Injectable Roadmap: Tues Oct 13, 16:00 CEST / 10 EDT

    Speakers: Mark Chipperfield (Corvus Ltd), Fabio Stevanon (CordenPharma), Umberto Romeo (CordenPharma)
    Key Learning Objectives:
    Review the fundamentals of combined injectable delivery device - drug products. Get an update on the latest regulation landscape for combined drug-device products, including some technical challenges for injectable Pre-Filled Syringes (PFS) & Auto-injectors. Gain insight into sound Injectable Drug Product strategy from a Full-Service CDMO industry leader. Learn about recent injectable industry changes facing Pharma, especially in the “New Normal” COVID-19 era, and how CordenPharma’s successful response & expanded capabilities can best support your drug development goals. Learn from an R&D Expert on ways to efficiently develop & commercialize an injectable drug.